左金丸通过TIPE1/PI3K/Akt信号通路抑制肿瘤相关巨噬细胞M2极化拮抗结直肠癌OA
Mechanisms of Zuojinwan in Inhibiting Tumor-associated Macrophage M2 Polarization Against Colorectal Cancer Through Regulation of TIPE1/PI3K/Akt Signaling Pathway
目的:从抑制肿瘤相关巨噬细胞 M2极化角度探讨左金丸治疗结直肠癌的作用机制.方法:氧化偶氮甲烷(AOM)/葡聚糖硫酸钠(DSS)诱导建立结直肠癌小鼠模型,记录体质量,计算疾病活动指数(DAI)和肿瘤数,苏木素-伊红(HE)染色观察结肠病理情况;酶联免疫吸附测定法(ELISA)检测小鼠结肠匀浆白细胞介素(IL)-6、转化生长因子-β(TGF-β)、IL-1β、肿瘤坏死因子-α(TNF-α)含量;免疫组化检测结肠增殖细胞核抗原(PCNA),免疫荧光检测巨噬细胞甘露糖受体(CD206)蛋白表达.体外利用IL-4/IL-13诱导M2型巨噬细胞,用不同体积分数左金丸含药血清干预巨噬细胞,流式细胞术检测CD206和分化簇86(CD86);建立CT26与RAW264.7巨噬细胞共培养体系,采用Transwell和台盼蓝检测CT26细胞迁移和增殖能力.最后采用蛋白组学筛选左金丸通过抑制肿瘤相关巨噬细胞M2极化治疗结直肠癌的关键蛋白及信号通路,蛋白免疫印迹法(Western blot)验证关键蛋白及信号通路.结果:动物实验中,与空白组比较,模型组小鼠体质量明显降低(P<0.05),DAI评分显著升高(P<0.01),结肠肿瘤数显著升高(P<0.01),结肠癌变程度高且出现淋巴转移,PCNA、CD206蛋白水平显著升高(P<0.01),结肠匀浆IL-6、IL-1β、TNF-α和TGF-β水平显著升高(P<0.01).与模型组比较,左金丸干预组小鼠体质量明显升高(P<0.05),DAI评分显著下降(P<0.01),肿瘤数显著下降(P<0.01),PCNA和CD206蛋白水平明显下降(P<0.05),结肠匀浆IL-6、IL-1β、TNF-α和 TGF-β水平明显下降(P<0.05).在体外 CT26与 RAW264.7共培养体系中,与空白组比较,与 M2型 RAW264.7共培养后,CT26细胞迁移率和增殖数显著上升(P<0.01).与M2组(M2型巨噬细胞)比较,左金丸含药血清组CD86比例显著升高(P<0.01),8%左金丸含药血清组的CT26细胞迁移率和增殖数显著下降(P<0.01).蛋白组学发现肿瘤坏死因子-α诱导蛋白8样蛋白1(TIPE1)可能是左金丸靶向巨噬细胞表型转化抑制结直肠癌的关键靶蛋白,磷脂酰肌醇3-激酶(PI3K)/蛋白激酶B(Akt)信号通路富集程度最高,与空白血清组比较,M2组巨噬细胞中TIPE1、p-PI3K和p-Akt水平明显升高(P<0.05,P<0.01).左金丸含药血清干预后TIPE1、p-PI3K和p-Akt水平明显下降(P<0.05,P<0.01).结论:左金丸可能通过抑制肿瘤相关巨噬细胞M2转化抑制结直肠癌增殖和迁移,这可能与其抑制肿瘤相关巨噬细胞中PI3K/Akt信号通路有关.
Objective:To investigate the mechanisms of Zuojinwan in the treatment of colorectal cancer from the perspective of inhibiting M2 polarization of tumor-associated macrophages.Methods:A colorectal cancer mouse model was established by azoxymethane(AOM)/dextran sulfate sodium(DSS).Body weight was recorded,disease activity index(DAI)and tumor number were calculated,and hematoxylin-eosin(HE)staining was used to observe colonic pathological changes.Enzyme-linked immunosorbent assay(ELISA)was used to detect the levels of interleukin-6(IL-6),transforming growth factor-β(TGF-β),interleukin-1β(IL-1β),and tumor necrosis factor-α(TNF-α)in colonic homogenates.Immunohistochemistry was used to detect proliferating cell nuclear antigen(PCNA)expression in the colon,and immunofluorescence was used to detect mannose receptor(CD206)expression in macrophages.In vitro,M2 macrophages were induced using IL-4/IL-13,and macrophages were treated with different concentrations of Zuojinwan-containing serum.CD206 and differentiation cluster 86(CD86)were analyzed by flow cytometry.A CT26 and RAW264.7 macrophage co-culture system was established,and the migration and proliferation abilities of CT26 cells were detected using Transwell assays and trypan blue exclusion.Finally,proteomics was used to screen key proteins and signaling pathways involved in Zuojinwan-mediated inhibition of M2 polarization of tumor-associated macrophages in colorectal cancer,and Western blot was used for validation.Results:In animal experiments,compared with the blank group,mice in the model group showed significantly decreased body weight(P<0.05),significantly increased DAI scores(P<0.01),and significantly increased tumor number(P<0.01),with severe colonic carcinogenesis and lymphatic metastasis.The protein expression levels of PCNA and CD206 were significantly increased(P<0.01),and the levels of IL-6,IL-1β,TNF-α,and TGF-β in colonic homogenates were significantly increased(P<0.01).Compared with the model group,mice in the Zuojinwan intervention group showed significantly higher body weight(P<0.05),significantly decreased DAI scores(P<0.01),and significantly reduced tumor numbers(P<0.01).The protein levels of PCNA and CD206 were significantly decreased(P<0.05),and the levels of IL-6,IL-1β,TNF-α,and TGF-β in colonic homogenates were significantly decreased(P<0.05).In the CT26 and RAW264.7 co-culture system in vitro,compared with the blank group,co-culture with M2-type RAW264.7 macrophages significantly increased CT26 cell migration rate and proliferation number(P<0.01).Compared with the M2 group(M2-type macrophages),the proportion of CD86 was significantly increased in the Zuojinwan-containing serum group(P<0.01),while the CT26 cell migration rate and proliferation number were significantly decreased in the 8%Zuojinwan-containing serum group(P<0.01).Proteomics analysis indicated that tumor necrosis factor-α-induced protein 8-like protein 1(TIPE1)may be a key target through which Zuojinwan regulates macrophage phenotypic transformation to inhibit colorectal cancer.The phosphatidylinositol 3-kinase(PI3K)/protein kinase B(Akt)signaling pathway showed the highest enrichment.Compared with the blank group,the levels of TIPE1,p-PI3K,and p-Akt in M2 macrophages were significantly increased(P<0.05,P<0.01).After treatment with Zuojinwan-containing serum,the levels of TIPE1,p-PI3K,and p-Akt were significantly decreased(P<0.05,P<0.01).Conclusion:Zuojinwan may inhibit colorectal cancer proliferation and migration by suppressing M2 polarization of tumor-associated macrophages,which may be associated with inhibition of the PI3K/Akt signaling pathway in tumor-associated macrophages.
农菲菲;幸尚平;邓舒烨
广西中医药大学 第一附属医院,中医药民族医药科学实验中心,广西中医药防治医学分子生物学重点实验室,南宁 530024广西医科大学 药学院 广西生物活性分子研究与评价重点实验室,南宁 530022广西中医药大学 第一附属医院,中医药民族医药科学实验中心,广西中医药防治医学分子生物学重点实验室,南宁 530024||广西中医药大学 广西教育厅中医临床研究重点实验室,南宁 530024
医药卫生
左金丸复方结直肠癌肿瘤相关巨噬细胞肿瘤坏死因子-α诱导蛋白8样蛋白1(TIPE1)/磷脂酰肌醇3-激酶(PI3K)/蛋白激酶B(Akt)信号通路
Zuojinwanformulacolorectal cancertumor-associated macrophagestumor necrosis factor-α-induced protein 8-like protein 1(TIPE1)/phosphatidylinositol 3-kinase(PI3K)/protein kinase B(Akt)signaling pathway
《中国实验方剂学杂志》 2026 (20)
22-32,11
国家自然科学基金项目(82460718)广西自然科学基金项目(2025GXNSFBA069323,2022JJB140189)广西中青年教师科研基础能力提升项目(2023KY0308,2022KY0280)广西青苗人才项目(0502405914)广西中医药大学博士启动基金项目(2022BS033)
评论